BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 11325821)

  • 1. Accelerated age-related CpG island methylation in ulcerative colitis.
    Issa JP; Ahuja N; Toyota M; Bronner MP; Brentnall TA
    Cancer Res; 2001 May; 61(9):3573-7. PubMed ID: 11325821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias.
    Konishi K; Shen L; Wang S; Meltzer SJ; Harpaz N; Issa JP
    Gastroenterology; 2007 Apr; 132(4):1254-60. PubMed ID: 17408633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
    Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
    Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG island methylation in premalignant stages of gastric carcinoma.
    Kang GH; Shim YH; Jung HY; Kim WH; Ro JY; Rhyu MG
    Cancer Res; 2001 Apr; 61(7):2847-51. PubMed ID: 11306456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer.
    Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Grieu F; Watanabe G; Iacopetta B
    Br J Cancer; 2006 Feb; 94(4):593-8. PubMed ID: 16421593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who takes the lead in the development of ulcerative colitis-associated colorectal cancers: mutator, suppressor, or methylator pathway?
    Maia L; Dinis J; Cravo M; Claro I; Baltazar C; Fonseca I; Veloso T; Capelinha AF; Carneiro F; Nobre-Leitão C
    Cancer Genet Cytogenet; 2005 Oct; 162(1):68-73. PubMed ID: 16157203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
    Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
    Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
    Toyota M; Ho C; Ahuja N; Jair KW; Li Q; Ohe-Toyota M; Baylin SB; Issa JP
    Cancer Res; 1999 May; 59(10):2307-12. PubMed ID: 10344734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of colorectal neoplasia by quantitative methylation analysis of estrogen receptor gene in nonneoplastic epithelium from patients with ulcerative colitis.
    Tominaga K; Fujii S; Mukawa K; Fujita M; Ichikawa K; Tomita S; Imai Y; Kanke K; Ono Y; Terano A; Hiraishi H; Fujimori T
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8880-5. PubMed ID: 16361578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant DNA methylation in ulcerative colitis without neoplasia.
    Wang FY; Arisawa T; Tahara T; Takahama K; Watanabe M; Hirata I; Nakano H
    Hepatogastroenterology; 2008; 55(81):62-5. PubMed ID: 18507080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma.
    Fogt F; Vortmeyer AO; Goldman H; Giordano TJ; Merino MJ; Zhuang Z
    Hum Pathol; 1998 Feb; 29(2):131-6. PubMed ID: 9490271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of MLH1 and MGMT genes in colon mucosa adjacent to implanted cancer in athymic mouse.
    Kuniyasu H; Sasaki T; Sasahira T; Chihara Y; Ohmori H
    J Exp Clin Cancer Res; 2004 Jun; 23(2):317-23. PubMed ID: 15354418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulcerative colitis-associated colorectal cancer is frequently associated with the microsatellite instability pathway.
    Fujiwara I; Yashiro M; Kubo N; Maeda K; Hirakawa K
    Dis Colon Rectum; 2008 Sep; 51(9):1387-94. PubMed ID: 18546042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis.
    Fujii S; Tominaga K; Kitajima K; Takeda J; Kusaka T; Fujita M; Ichikawa K; Tomita S; Ohkura Y; Ono Y; Imura J; Chiba T; Fujimori T
    Gut; 2005 Sep; 54(9):1287-92. PubMed ID: 15870230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia.
    Waki T; Tamura G; Tsuchiya T; Sato K; Nishizuka S; Motoyama T
    Am J Pathol; 2002 Aug; 161(2):399-403. PubMed ID: 12163364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related hypermethylation of the 5' region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development.
    Nakagawa H; Nuovo GJ; Zervos EE; Martin EW; Salovaara R; Aaltonen LA; de la Chapelle A
    Cancer Res; 2001 Oct; 61(19):6991-5. PubMed ID: 11585722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive DNA Methylation Profiling of Inflammatory Mucosa in Ulcerative Colitis.
    Tahara T; Hirata I; Nakano N; Nagasaka M; Nakagawa Y; Shibata T; Ohmiya N
    Inflamm Bowel Dis; 2017 Jan; 23(1):165-173. PubMed ID: 27930411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
    Kuester D; Guenther T; Biesold S; Hartmann A; Bataille F; Ruemmele P; Peters B; Meyer F; Schubert D; Bohr UR; Malfertheiner P; Lippert H; Silver AR; Roessner A; Schneider-Stock R
    Pathol Res Pract; 2010 Sep; 206(9):616-24. PubMed ID: 20630662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.